Skip to main content
Tessa NewsLink
Paste a health news link, or browse
Latest checks

Source study found

Story checked

Scientists Say a Simple Blood Test Could Reveal Depression (opens in a new tab)

scitechdaily.com · 2026-10-21

Short answerEvidenceSource

Short answer

Mixed

Mixed.

One claim goes further than the study. One other point was not covered by the paper.

  • 3 supported
  • 1 overstated
  • 1 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Mixed

One claim overstates the study. Three of five check out. One claim the study doesn't address.

  • 3 supported
  • 1 overstated
  • 1 not covered
Open claim evidence
3
Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

5 claims in this story

Showing all 5 claimsChoose a verdict to focus the list.

Claim 1 of 5OverstatedThe study found that measuring how quickly these immune cells age can help predict emotional and cognitive symptoms of depression, including hopelessness and loss of pleasure, but not physical symptoms such as fatigue or changes in appetite.View evidenceHide evidence

Why this verdict

The underlying association with non-somatic symptoms and anhedonia is supported. However, saying the measure 'can help predict' symptoms is stronger than the abstract-level evidence, which reports cross-sectional regression associations rather than validated predictive performance or clinical prediction. The 'not physical symptoms' contrast is broadly consistent with the domain framing, but the profile does not provide detailed somatic-domain estimates.

1

Study evidence

In the overall sample, higher monocyte epigenetic age acceleration (EAAMono) was associated with greater non-somatic depressive symptoms after adjustment for HIV, race, and ethnicity.standardized β = 0.125 (p = .018)

“DNA methylation data and Center for Epidemiologic Studies Depression Scale (CES-D) scores were available from 440 Women's Interagency HIV Study participants.”
Claim 2 of 5Not coveredThe article says the findings were published in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences and were based on 440 participants in the Women’s Interagency HIV Study, including women with and without HIV.View evidenceHide evidence

As stated440 participants; 261 women with HIV and 179 without HIV

Why this verdict

The supplied profile supports the WIHS sample size and composition: 440 participants, including 261 women with HIV and 179 without HIV. However, the journal/publication venue named in the story is not present in the supplied abstract-level profile, so that part is not verifiable from the provided evidence.

1

Study evidence

In the overall sample, higher monocyte epigenetic age acceleration (EAAMono) was associated with greater non-somatic depressive symptoms after adjustment for HIV, race, and ethnicity.standardized β = 0.125 (p = .018)

“DNA methylation data and Center for Epidemiologic Studies Depression Scale (CES-D) scores were available from 440 Women's Interagency HIV Study participants.”
2

Study evidence

Epigenetic age acceleration derived from HorvathDNAmAge (EAAHorvath), orthogonalized to chronological age, was not associated with depressive symptom severity or with depressive symptom domains in the WIHS sample (overall and HIV-stratified analyses) as reported in the abstract.

“Two biological age estimates (HorvathDNAmAge and MonoDNAmAge) were calculated and orthogonalized with chronological age.”
Claim 3 of 5SupportedScientists have discovered that the biological aging of certain white blood cells may provide an important clue to depression, potentially opening the door to a blood test that could help identify the condition.View evidenceHide evidence

Why this verdict

The abstract-level profile supports a hedged association between monocyte-specific epigenetic age acceleration and non-somatic depressive symptoms/anhedonia in women from WIHS. The blood-test framing is translational and speculative, but the claim is hedged ('may,' 'potentially') and the story reportedly notes that no clinical test exists, so it does not materially outrun the paper at this depth.

1

Study evidence

In the overall sample, higher monocyte epigenetic age acceleration (EAAMono) was associated with greater non-somatic depressive symptoms after adjustment for HIV, race, and ethnicity.standardized β = 0.125 (p = .018)

“DNA methylation data and Center for Epidemiologic Studies Depression Scale (CES-D) scores were available from 440 Women's Interagency HIV Study participants.”
Claim 4 of 5SupportedResearchers used two epigenetic clocks, including one focused on monocytes, and report that monocyte aging was associated with nonphysical depression symptoms while the broader clock showed no association.View evidenceHide evidence

Why this verdict

The profile states that two biological age estimates were calculated: MonoDNAmAge and HorvathDNAmAge. It supports that monocyte-specific epigenetic age acceleration was associated with non-somatic depressive symptoms and anhedonia, while HorvathDNAmAge-derived acceleration was not associated with depression severity or symptom domains.

1

Study evidence

In the overall sample, higher monocyte epigenetic age acceleration (EAAMono) was associated with greater non-somatic depressive symptoms after adjustment for HIV, race, and ethnicity.standardized β = 0.125 (p = .018)

“DNA methylation data and Center for Epidemiologic Studies Depression Scale (CES-D) scores were available from 440 Women's Interagency HIV Study participants.”
2

Study evidence

Epigenetic age acceleration derived from HorvathDNAmAge (EAAHorvath), orthogonalized to chronological age, was not associated with depressive symptom severity or with depressive symptom domains in the WIHS sample (overall and HIV-stratified analyses) as reported in the abstract.

“Two biological age estimates (HorvathDNAmAge and MonoDNAmAge) were calculated and orthogonalized with chronological age.”
Claim 5 of 5SupportedThe article stresses that the result does not establish a clinically validated blood test for depression and that additional research is needed before it could be used in routine diagnosis or treatment.View evidenceHide evidence

Why this verdict

This caveat is consistent with the paper profile. The study is cross-sectional and observational, reports associations rather than validation of a diagnostic blood test, and has generalizability and residual-confounding limitations. The profile supports the need for further research before any routine diagnostic or treatment use.

1

Study evidence

In the overall sample, higher monocyte epigenetic age acceleration (EAAMono) was associated with greater non-somatic depressive symptoms after adjustment for HIV, race, and ethnicity.standardized β = 0.125 (p = .018)

“DNA methylation data and Center for Epidemiologic Studies Depression Scale (CES-D) scores were available from 440 Women's Interagency HIV Study participants.”
2

Study evidence

Epigenetic age acceleration derived from HorvathDNAmAge (EAAHorvath), orthogonalized to chronological age, was not associated with depressive symptom severity or with depressive symptom domains in the WIHS sample (overall and HIV-stratified analyses) as reported in the abstract.

“Two biological age estimates (HorvathDNAmAge and MonoDNAmAge) were calculated and orthogonalized with chronological age.”
Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

  • The study was a cross-sectional observational analysis of WIHS cohort data, not an intervention or longitudinal validation study.

    The story presentation uses associational language and cautions against a current clinical test, but its listed caveats do not explicitly mention the cross-sectional design or the resulting inability to infer temporal direction or causality.

    From Cross-sectional observational analysis of cohort data; secondary_data observational comparator analysis

  • The reported overall-sample effect sizes were standardized β = 0.125 for non-somatic symptoms and β = 0.354 for anhedonia.

    The story does not report the magnitude or p-values of the associations. This omission matters because the headline-style 'important clue' and blood-test framing would be better calibrated by the actual association sizes.

    From Cross-sectional observational analysis of cohort data

  • Residual confounding cannot be excluded because the abstract specifies limited covariate information beyond adjustment for HIV status, race, and ethnicity.

    The story caveats mention lack of clinical validation and need for further research, but they do not mention residual confounding or the limited covariate detail available at abstract depth.

    From Cross-sectional observational analysis of cohort data; secondary_data observational comparator analysis

4 things the story did carry across
  • Data came from 440 Women's Interagency HIV Study participants, including women with and without HIV.
  • MonoDNAmAge-based epigenetic age acceleration was associated with non-somatic depressive symptoms and anhedonia in the overall sample.
  • HorvathDNAmAge-derived epigenetic age acceleration was not associated with depression severity or symptom domains.
  • Generalizability is limited to women enrolled in WIHS, and broader applicability to other populations is not established at abstract depth.
Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

2

Evidence read

study summary

Lead result

secondary data

1Lead resultsecondary dataTest whether monocyte epigenetic age acceleration (MonoDNAmAge-based EAA) is associated with depressive symptom severity and symptom domains (non-somatic vs somatic; anhedonia) in women, overall and stratified by HIV status, using WIHS data.Cross-sectional observational analysis of cohort dataExpand

In plain English

Cross-sectional analysis of 440 Women’s Interagency HIV Study participants testing whether monocyte-specific epigenetic age acceleration (EAAMono, derived from MonoDNAmAge and orthogonalized to chronological age) is associated with depressive symptom severity and domains (non-somatic vs somatic; anhedonia). Multiple linear regression models (standardized β reported) were fit in the full sample and stratified by HIV status, with adjustment for HIV status, race, and ethnicity. In the overall sample, higher EAAMono was associated with greater non-somatic depressive symptoms (β = 0.125, p = .018) and with anhedonia (β = 0.354, p = .007); the association with non-somatic symptoms showed a similar but attenuated pattern in the subsample with HIV (β = 0.112, p = .085). The comparator Horvath DNAm age acceleration (EAAHorvath) was not associated with depression severity or symptom domains.

Key findings

  • In the overall sample, higher monocyte epigenetic age acceleration (EAAMono) was associated with greater non-somatic depressive symptoms after adjustment for HIV, race, and ethnicity.standardized β = 0.125 (p = .018)
  • In the overall sample, EAAMono was associated with anhedonia specifically.standardized β = 0.354 (p = .007)
“DNA methylation data and Center for Epidemiologic Studies Depression Scale (CES-D) scores were available from 440 Women's Interagency HIV Study participants.”
What this piece can’t prove
  • Cross-sectional observational design limits causal inference.
  • Abstract provides limited detail on additional covariates or sensitivity analyses (e.g., smoking, body mass index, antiretroviral therapy), so residual confounding cannot be excluded.
  • Generalizability limited to women enrolled in WIHS; demographic composition reported but broader applicability not established in abstract.
2secondary dataCompare a general DNAm clock (HorvathDNAmAge-based EAA) versus MonoDNAmAge-based EAA for associations with depressive symptoms to evaluate specificity of the monocyte clock signal.secondary data observational comparator analysisExpand

In plain English

In the same WIHS sample and regression framework used to test MonoDNAmAge, HorvathDNAmAge-derived epigenetic age acceleration (EAAHorvath), computed and orthogonalized to chronological age, showed no association with depressive symptom severity or symptom domains (per abstract-level report). Multiple linear regression models (standardized β reported) and HIV-stratified analyses were used to evaluate these associations.

Key findings

  • Epigenetic age acceleration derived from HorvathDNAmAge (EAAHorvath), orthogonalized to chronological age, was not associated with depressive symptom severity or with depressive symptom domains in the WIHS sample (overall and HIV-stratified analyses) as reported in the abstract.
“Two biological age estimates (HorvathDNAmAge and MonoDNAmAge) were calculated and orthogonalized with chronological age.”
What this piece can’t prove
  • Cross-sectional design precludes causal conclusions.
  • Study population limited to women from WIHS; stratified subgroup sizes may limit power to detect small effects.

2 further details could not be confirmed from the summary.

Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Papers considered

The selected paper, plus nearby candidates.

PubMed, Europe PMC, Crossref · 36 candidate papers

Candidate

Acknowledgment of Reviewers 2025

The Journals of Gerontology, Series a: Biological Sciences and Medical Sciences · 2026 · Crossref

Source (opens in a new tab)
Candidate

Acknowledgment of Reviewers

The Journals of Gerontology, Series B: Psychological Sciences and Social Sciences · 2026 · Crossref

Source (opens in a new tab)

And 30 more candidates considered.